Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
CN
Home/Newsroom/News

News 2021-08-16

Porton Reports Strong Half-Year Results

Porton Reports Strong Half-Year Results

Others
More

News 2025-12-30

Porton Achieves EU QP Certification for Chongqing Manufacturing Facility

Porton Pharma's Chongqing facility successfully completes EU QP Audit. Third site to meet European quality standards for drug manufacturing.
Complex Antibody Therapies

News 2025-12-23

Porton&Nona: Strategic Partnership for Complex Antibody Therapy

Global biotech Nona partners with CDMO Porton to accelerate complex antibody drug development and commercialization.
Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200